APO Research
Talk to an analyst

APO RESEARCH · REPORT

GMP Plasmid Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global GMP Plasmid Service Market Outlook and Growth Opportunities 2026

28 December 2025198 pages

Choose your research edition.

Industry ResearchGMP Plasmid Service Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal GMP Plasmid Service Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal GMP Plasmid Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GMP Plasmid Service Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal GMP Plasmid Service Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global GMP Plasmid Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for GMP Plasmid Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GMP Plasmid Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GMP Plasmid Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the GMP Plasmid Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the GMP Plasmid Service market include Aldevron, Andelyn Biosciences, Anemocyte, Catalent Biologics, Creative Biolabs, Esco Aster, VectorBuilder, Eurogentec and Pharmaron, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global GMP Plasmid Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GMP Plasmid Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GMP Plasmid Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global GMP Plasmid Service market.

GMP Plasmid Service Segment by Company

Aldevron

Andelyn Biosciences

Anemocyte

Catalent Biologics

Creative Biolabs

Esco Aster

VectorBuilder

Eurogentec

Pharmaron

PlasmidFactory GmbH

ProBio CDMO

Sartorius

Takara Bio

GMP Plasmid Service Segment by Type

Plasmid for Viral Vector Production

Plasmid for Direct-Acting Therapeutics

Plasmid for In Vitro Transcription Template

Others

GMP Plasmid Service Segment by Application

Gene Therapy and Cell Therapy Industry

mRNA Vaccine and Therapy Industry

Diagnostic and Scientific Research Reagent Industry

Others

GMP Plasmid Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global GMP Plasmid Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the GMP Plasmid Service key companies, revenue, market share, and recent developments.

3. To split the GMP Plasmid Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions GMP Plasmid Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify GMP Plasmid Service significant trends, drivers, influence factors in global and regions.

6. To analyze GMP Plasmid Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Plasmid Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GMP Plasmid Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Plasmid Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GMP Plasmid Service industry.

Chapter 3: Detailed analysis of GMP Plasmid Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of GMP Plasmid Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of GMP Plasmid Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. GMP Plasmid Service Industry Trends Table 2. GMP Plasmid Service Industry Drivers Table 3. GMP Plasmid Service Industry Opportunities and Challenges Table 4. GMP Plasmid Service Industry Restraints Table 5. Global GMP Plasmid Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global GMP Plasmid Service Revenue Share by Company (2021-2026) Table 7. Global GMP Plasmid Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global GMP Plasmid Service Key Company Manufacturing Base & Headquarters Table 9. Global GMP Plasmid Service Company, Product Type & Application Table 10. Global GMP Plasmid Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global GMP Plasmid Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Plasmid for Viral Vector Production Table 15. Significant Companies of Plasmid for Direct-Acting Therapeutics Table 16. Significant Companies of Plasmid for In Vitro Transcription Template Table 17. Significant Companies of Others Table 18. Global GMP Plasmid Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global GMP Plasmid Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global GMP Plasmid Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global GMP Plasmid Service Sales Value Share by Type (2021-2026) Table 22. Global GMP Plasmid Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Gene Therapy and Cell Therapy Industry Table 24. Significant Companies of mRNA Vaccine and Therapy Industry Table 25. Significant Companies of Diagnostic and Scientific Research Reagent Industry Table 26. Significant Companies of Others Table 27. Global GMP Plasmid Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global GMP Plasmid Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global GMP Plasmid Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global GMP Plasmid Service Sales Value Share by Application (2021-2026) Table 31. Global GMP Plasmid Service Sales Value Share by Application (2027-2032) Table 32. Global GMP Plasmid Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global GMP Plasmid Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global GMP Plasmid Service Sales Value Share by Region (2021-2026) Table 35. Global GMP Plasmid Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global GMP Plasmid Service Sales Value Share by Region (2027-2032) Table 37. Global GMP Plasmid Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global GMP Plasmid Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global GMP Plasmid Service Sales Value Market Share by Country (2021-2026) Table 40. Global GMP Plasmid Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global GMP Plasmid Service Sales Value Market Share by Country (2027-2032) Table 42. Aldevron Company Information Table 43. Aldevron Business Overview Table 44. Aldevron GMP Plasmid Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Aldevron GMP Plasmid Service Product Portfolio Table 46. Aldevron Recent Development Table 47. Andelyn Biosciences Company Information Table 48. Andelyn Biosciences Business Overview Table 49. Andelyn Biosciences GMP Plasmid Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Andelyn Biosciences GMP Plasmid Service Product Portfolio Table 51. Andelyn Biosciences Recent Development Table 52. Anemocyte Company Information Table 53. Anemocyte Business Overview Table 54. Anemocyte GMP Plasmid Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Anemocyte GMP Plasmid Service Product Portfolio Table 56. Anemocyte Recent Development Table 57. Catalent Biologics Company Information Table 58. Catalent Biologics Business Overview Table 59. Catalent Biologics GMP Plasmid Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Catalent Biologics GMP Plasmid Service Product Portfolio Table 61. Catalent Biologics Recent Development Table 62. Creative Biolabs Company Information Table 63. Creative Biolabs Business Overview Table 64. Creative Biolabs GMP Plasmid Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Creative Biolabs GMP Plasmid Service Product Portfolio Table 66. Creative Biolabs Recent Development Table 67. Esco Aster Company Information Table 68. Esco Aster Business Overview Table 69. Esco Aster GMP Plasmid Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Esco Aster GMP Plasmid Service Product Portfolio Table 71. Esco Aster Recent Development Table 72. VectorBuilder Company Information Table 73. VectorBuilder Business Overview Table 74. VectorBuilder GMP Plasmid Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. VectorBuilder GMP Plasmid Service Product Portfolio Table 76. VectorBuilder Recent Development Table 77. Eurogentec Company Information Table 78. Eurogentec Business Overview Table 79. Eurogentec GMP Plasmid Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Eurogentec GMP Plasmid Service Product Portfolio Table 81. Eurogentec Recent Development Table 82. Pharmaron Company Information Table 83. Pharmaron Business Overview Table 84. Pharmaron GMP Plasmid Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pharmaron GMP Plasmid Service Product Portfolio Table 86. Pharmaron Recent Development Table 87. PlasmidFactory GmbH Company Information Table 88. PlasmidFactory GmbH Business Overview Table 89. PlasmidFactory GmbH GMP Plasmid Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. PlasmidFactory GmbH GMP Plasmid Service Product Portfolio Table 91. PlasmidFactory GmbH Recent Development Table 92. ProBio CDMO Company Information Table 93. ProBio CDMO Business Overview Table 94. ProBio CDMO GMP Plasmid Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. ProBio CDMO GMP Plasmid Service Product Portfolio Table 96. ProBio CDMO Recent Development Table 97. Sartorius Company Information Table 98. Sartorius Business Overview Table 99. Sartorius GMP Plasmid Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sartorius GMP Plasmid Service Product Portfolio Table 101. Sartorius Recent Development Table 102. Takara Bio Company Information Table 103. Takara Bio Business Overview Table 104. Takara Bio GMP Plasmid Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Takara Bio GMP Plasmid Service Product Portfolio Table 106. Takara Bio Recent Development Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. GMP Plasmid Service Product Image Figure 2. Global GMP Plasmid Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GMP Plasmid Service Market Size (2021-2032) & (US$ Million) Figure 4. Global GMP Plasmid Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Plasmid for Viral Vector Production Image Figure 8. Plasmid for Direct-Acting Therapeutics Image Figure 9. Plasmid for In Vitro Transcription Template Image Figure 10. Others Image Figure 11. Global GMP Plasmid Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global GMP Plasmid Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global GMP Plasmid Service Sales Value Share by Type (2021-2032) Figure 14. Gene Therapy and Cell Therapy Industry Image Figure 15. mRNA Vaccine and Therapy Industry Image Figure 16. Diagnostic and Scientific Research Reagent Industry Image Figure 17. Others Image Figure 18. Global GMP Plasmid Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global GMP Plasmid Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global GMP Plasmid Service Sales Value Share by Application (2021-2032) Figure 21. Global GMP Plasmid Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global GMP Plasmid Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America GMP Plasmid Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America GMP Plasmid Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe GMP Plasmid Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe GMP Plasmid Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific GMP Plasmid Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific GMP Plasmid Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America GMP Plasmid Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America GMP Plasmid Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa GMP Plasmid Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa GMP Plasmid Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt GMP Plasmid Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmid for Viral Vector Production
  • Plasmid for Direct-Acting Therapeutics
  • Plasmid for In Vitro Transcription Template
  • Others
Applications
  • Gene Therapy and Cell Therapy Industry
  • mRNA Vaccine and Therapy Industry
  • Diagnostic and Scientific Research Reagent Industry
  • Others
Companies covered
  • Aldevron
  • Andelyn Biosciences
  • Anemocyte
  • Catalent Biologics
  • Creative Biolabs
  • Esco Aster
  • VectorBuilder
  • Eurogentec
  • Pharmaron
  • PlasmidFactory GmbH
  • ProBio CDMO
  • Sartorius
  • Takara Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global GMP Plasmid Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global GMP Plasmid Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 GMP Plasmid Service Market Dynamics
  1. 2.1 GMP Plasmid Service Industry Trends
  2. 2.2 GMP Plasmid Service Industry Drivers
  3. 2.3 GMP Plasmid Service Industry Opportunities and Challenges
  4. 2.4 GMP Plasmid Service Industry Restraints
3 GMP Plasmid Service Market by Company
  1. 3.1 Global GMP Plasmid Service Company Revenue Ranking in 2025
  2. 3.2 Global GMP Plasmid Service Revenue by Company (2021-2026)
  3. 3.3 Global GMP Plasmid Service Company Ranking (2024-2026)
  4. 3.4 Global GMP Plasmid Service Company Manufacturing Base and Headquarters
  5. 3.5 Global GMP Plasmid Service Company Product Type and Application
  6. 3.6 Global GMP Plasmid Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global GMP Plasmid Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 GMP Plasmid Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 GMP Plasmid Service Market by Type
  1. 4.1 GMP Plasmid Service Type Introduction
  2. 4.1.1 Plasmid for Viral Vector Production
  3. 4.1.2 Plasmid for Direct-Acting Therapeutics
  4. 4.1.3 Plasmid for In Vitro Transcription Template
  5. 4.1.4 Others
  6. 4.2 Global GMP Plasmid Service Sales Value by Type
  7. 4.2.1 Global GMP Plasmid Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global GMP Plasmid Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global GMP Plasmid Service Sales Value Share by Type (2021-2032)
5 GMP Plasmid Service Market by Application
  1. 5.1 GMP Plasmid Service Application Introduction
  2. 5.1.1 Gene Therapy and Cell Therapy Industry
  3. 5.1.2 mRNA Vaccine and Therapy Industry
  4. 5.1.3 Diagnostic and Scientific Research Reagent Industry
  5. 5.1.4 Others
  6. 5.2 Global GMP Plasmid Service Sales Value by Application
  7. 5.2.1 Global GMP Plasmid Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global GMP Plasmid Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global GMP Plasmid Service Sales Value Share by Application (2021-2032)
6 GMP Plasmid Service Regional Value Analysis
  1. 6.1 Global GMP Plasmid Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GMP Plasmid Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global GMP Plasmid Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global GMP Plasmid Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America GMP Plasmid Service Sales Value (2021-2032)
  7. 6.3.2 North America GMP Plasmid Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe GMP Plasmid Service Sales Value (2021-2032)
  10. 6.4.2 Europe GMP Plasmid Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific GMP Plasmid Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific GMP Plasmid Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America GMP Plasmid Service Sales Value (2021-2032)
  16. 6.6.2 South America GMP Plasmid Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa GMP Plasmid Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa GMP Plasmid Service Sales Value Share by Country, 2025 VS 2032
7 GMP Plasmid Service Country-level Value Analysis
  1. 7.1 Global GMP Plasmid Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global GMP Plasmid Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global GMP Plasmid Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global GMP Plasmid Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt GMP Plasmid Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt GMP Plasmid Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt GMP Plasmid Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aldevron
  2. 8.1.1 Aldevron Company Information
  3. 8.1.2 Aldevron Business Overview
  4. 8.1.3 Aldevron GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aldevron GMP Plasmid Service Product Portfolio
  6. 8.1.5 Aldevron Recent Developments
  7. 8.2 Andelyn Biosciences
  8. 8.2.1 Andelyn Biosciences Company Information
  9. 8.2.2 Andelyn Biosciences Business Overview
  10. 8.2.3 Andelyn Biosciences GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Andelyn Biosciences GMP Plasmid Service Product Portfolio
  12. 8.2.5 Andelyn Biosciences Recent Developments
  13. 8.3 Anemocyte
  14. 8.3.1 Anemocyte Company Information
  15. 8.3.2 Anemocyte Business Overview
  16. 8.3.3 Anemocyte GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Anemocyte GMP Plasmid Service Product Portfolio
  18. 8.3.5 Anemocyte Recent Developments
  19. 8.4 Catalent Biologics
  20. 8.4.1 Catalent Biologics Company Information
  21. 8.4.2 Catalent Biologics Business Overview
  22. 8.4.3 Catalent Biologics GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Catalent Biologics GMP Plasmid Service Product Portfolio
  24. 8.4.5 Catalent Biologics Recent Developments
  25. 8.5 Creative Biolabs
  26. 8.5.1 Creative Biolabs Company Information
  27. 8.5.2 Creative Biolabs Business Overview
  28. 8.5.3 Creative Biolabs GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Creative Biolabs GMP Plasmid Service Product Portfolio
  30. 8.5.5 Creative Biolabs Recent Developments
  31. 8.6 Esco Aster
  32. 8.6.1 Esco Aster Company Information
  33. 8.6.2 Esco Aster Business Overview
  34. 8.6.3 Esco Aster GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Esco Aster GMP Plasmid Service Product Portfolio
  36. 8.6.5 Esco Aster Recent Developments
  37. 8.7 VectorBuilder
  38. 8.7.1 VectorBuilder Company Information
  39. 8.7.2 VectorBuilder Business Overview
  40. 8.7.3 VectorBuilder GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 VectorBuilder GMP Plasmid Service Product Portfolio
  42. 8.7.5 VectorBuilder Recent Developments
  43. 8.8 Eurogentec
  44. 8.8.1 Eurogentec Company Information
  45. 8.8.2 Eurogentec Business Overview
  46. 8.8.3 Eurogentec GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eurogentec GMP Plasmid Service Product Portfolio
  48. 8.8.5 Eurogentec Recent Developments
  49. 8.9 Pharmaron
  50. 8.9.1 Pharmaron Company Information
  51. 8.9.2 Pharmaron Business Overview
  52. 8.9.3 Pharmaron GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pharmaron GMP Plasmid Service Product Portfolio
  54. 8.9.5 Pharmaron Recent Developments
  55. 8.10 PlasmidFactory GmbH
  56. 8.10.1 PlasmidFactory GmbH Company Information
  57. 8.10.2 PlasmidFactory GmbH Business Overview
  58. 8.10.3 PlasmidFactory GmbH GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 PlasmidFactory GmbH GMP Plasmid Service Product Portfolio
  60. 8.10.5 PlasmidFactory GmbH Recent Developments
  61. 8.11 ProBio CDMO
  62. 8.11.1 ProBio CDMO Company Information
  63. 8.11.2 ProBio CDMO Business Overview
  64. 8.11.3 ProBio CDMO GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ProBio CDMO GMP Plasmid Service Product Portfolio
  66. 8.11.5 ProBio CDMO Recent Developments
  67. 8.12 Sartorius
  68. 8.12.1 Sartorius Company Information
  69. 8.12.2 Sartorius Business Overview
  70. 8.12.3 Sartorius GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sartorius GMP Plasmid Service Product Portfolio
  72. 8.12.5 Sartorius Recent Developments
  73. 8.13 Takara Bio
  74. 8.13.1 Takara Bio Company Information
  75. 8.13.2 Takara Bio Business Overview
  76. 8.13.3 Takara Bio GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Takara Bio GMP Plasmid Service Product Portfolio
  78. 8.13.5 Takara Bio Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst